Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-016571

Options or other derivatives

  • Chief Financial Officer acquired 75,102 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick Chief Financial Officer 2019-03-19 Grant or award · Employee Stock Option (right to buy) +75,102 75,102 D
Loading xslF345X03/a4.xml…